Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gottlieb Becomes US FDA Commissioner With Immediate Issues Pending

May 10 2017

• By Derrick Gingery

FDA entrance sign 2016

Related Content

First Draft FDA User Fee Bill Is Squeaky Clean

Apr 14 2017

Opioid Policy At US FDA: Gottlieb Seeks More Activist Role To Combat Abuse

Apr 07 2017

Gottlieb's Confirmation: Will Industry Ties Remain A Big Deal After The Hearing?

Apr 03 2017

US FDA Gains Budget Increase In FY 2017… And Not Through Fees

May 01 2017

Gottlieb Closing In On Confirmation Despite Senate Concern On Opioids

May 09 2017

Trump's Budget Outline Threatens User Fee Agreements

Mar 17 2017

FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?

Jan 31 2017

US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure

Jan 05 2017

FDA's Document Dump: Guidance Release Skyrockets Ahead Of Trump's Arrival

Jan 22 2017

Ostroff: Administration Coming Up To Speed On Planned FDA Guidances

May 05 2017

Califf Maintains Desire To Stay At FDA, But Would Either Presidential Candidate Keep Him?

Nov 05 2016

Additional Topics

United States FDA Leadership Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window